Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries Limited American Depositary Shares (NY: TEVA )

21.86 +0.07 (+0.30%)
Streaming Delayed Price Updated: 2:35 PM EST, Jan 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,200,624
Open 21.80
Bid (Size) 21.85 (3)
Ask (Size) 21.86 (19)
Prev. Close 21.79
Today's Range 21.65 - 21.98
52wk Range 11.48 - 22.80
Shares Outstanding 1,110,352,397
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
FDA Warns Of Severe Allergic Reaction Risk With Teva's Multiple Sclerosis Drug
FDA issues new warnings about rare but severe allergic reactions, including anaphylaxis, linked to MS drug glatiramer acetate, urging immediate medical attention. 
Via Benzinga
Exposures Product Safety
Promising Signs: TEVA PHARMACEUTICAL-SP ADR Setting the Stage for a Breakout.
TEVA PHARMACEUTICAL-SP ADR (NYSE:TEVA) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill

Performance

YTD
+2.61%
+2.61%
1 Month
-2.52%
-2.52%
3 Month
+19.75%
+19.75%
6 Month
+30.09%
+30.09%
1 Year
+82.58%
+82.58%

More News

Read More
Teva Challenges Drug Price Law's Impact On Innovation, Generics
Via Benzinga
Topics Economy
Exposures Interest Rates
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Via Benzinga
Topics Economy
Exposures Interest Rates
Nvidia To Rally Around 31%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Teva Announces Collaboration to Commercialize Formycon’s Biosimilar Candidate to Eylea® (aflibercept) in major parts of Europe and in Israel
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Samsung Bioepis and Teva Enter into a Strategic Partnership for Commercialization of EPYSQLI® (eculizumab-aagh) in the United States
From Teva Pharmaceutical Industries Ltd; Samsung Bioepis Co., Ltd.
Via GlobeNewswire
Catalyst Pharmaceuticals Settles Patent Litigation Case With Teva Pharmaceutical
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property
IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
Via Investor's Business Daily
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Via Benzinga
Exposures Product Safety
Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas
Via Benzinga
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Teva to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Via Benzinga
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
Via Benzinga
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and 2025 Financial Guidance at 8 a.m. ET on January 29, 2025
From Teva Pharmaceutical Industries Ltd
Via GlobeNewswire
My Top 10 Portfolio Holdings for 2025
Via The Motley Fool
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Via Benzinga
Nukkleus, Micron, Teva Pharmaceutical, Quantum Computing, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday
Via Benzinga
Teva Catapults 20%, Nearing A Five-Year High, After Scoring A Win With Sanofi-Tied Drug
Via Investor's Business Daily
Why Are Teva And Sanofi Stocks Trading Higher On Tuesday?
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.